Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 32124 [2018-14755]

Download as PDF 32124 Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices category for purposes of applying the disclosure thresholds. OGE is also proposing to update the Privacy Act Statement in accordance with changes to the applicable system of records, update the examples provided on the last page of the form, and make other minor technical changes. Request for Comments: OGE is publishing this first round notice of its intent to request paperwork clearance for a proposed modified OGE Form 450. Public comment is invited specifically on the need for and practical utility of this information collection, the accuracy of OGE’s burden estimate, the enhancement of quality, utility and clarity of the information collected, and the minimization of burden (including the use of information technology). Comments received in response to this notice will be summarized for, and may be included with, the OGE request for extension of OMB paperwork approval. The comments will also become a matter of public record. Approved: July 3, 2018. David Apol, Acting Director and General Counsel, Office of Government Ethics. [FR Doc. 2018–14841 Filed 7–10–18; 8:45 am] BILLING CODE 6345–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public, limited only by 60 room seating and 100 ports for audio phone lines. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is Monday, August 13, 2018. Persons who desire to make an oral statement, may request it at the time of the public comment period on August 21, 2018 at 3:20 p.m., EDT. daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:26 Jul 10, 2018 Jkt 244001 The meeting will be held on August 21, 2018, 10:00 a.m. to 3:30 p.m., EDT. DATES: 8 Corporate Blvd., Building 8, Conference Rooms 1A and 1B, Atlanta, Georgia 30329 and Web conference: 1–877–927–1433 and participant passcode: 12016435 and https://adobeconnect.cdc.gov/ r5p8l2tytpq/. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E–07, Atlanta, Georgia 30329–4018, telephone (404) 639–8317; zkr7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Considered: The agenda will include discussions on (1) Isoniazid-Rifapentine TB Prevention in HIV-infected Persons Study; (2) Division of HIV/AIDS Prevention’s Strategy of Adopting HIV Treatment as Prevention; (3) Update on Division of Tuberculosis Elimination’s Concept of Operations for Latent Tuberculosis Infection Surveillance; and (4) Update from ACET workgroups. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–14755 Filed 7–10–18; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women, Centers for Disease Control and Prevention; Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of charter renewal. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Advisory Committee on Breast Cancer in Young Women (ACBCYW), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through June 17, 2020. FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 5770 Buford Highway NE, Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760. Email: acbcyw@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. SUMMARY: Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–14756 Filed 7–10–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–18–0572] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Health Message Testing System (HMTS) to the Office of Management and Budget (OMB) for review and approval. CDC previously E:\FR\FM\11JYN1.SGM 11JYN1

Agencies

[Federal Register Volume 83, Number 133 (Wednesday, July 11, 2018)]
[Notices]
[Page 32124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14755]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the 
public, limited only by 60 room seating and 100 ports for audio phone 
lines. Time will be available for public comment. The public is welcome 
to submit written comments in advance of the meeting. Comments should 
be submitted in writing by email to the contact person listed below. 
The deadline for receipt is Monday, August 13, 2018. Persons who desire 
to make an oral statement, may request it at the time of the public 
comment period on August 21, 2018 at 3:20 p.m., EDT.

DATES: The meeting will be held on August 21, 2018, 10:00 a.m. to 3:30 
p.m., EDT.

ADDRESSES: 8 Corporate Blvd., Building 8, Conference Rooms 1A and 1B, 
Atlanta, Georgia 30329 and Web conference: 1-877-927-1433 and 
participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l2tytpq/.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30329-4018, telephone (404) 639-8317; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: This Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters To Be Considered: The agenda will include discussions on 
(1) Isoniazid-Rifapentine TB Prevention in HIV-infected Persons Study; 
(2) Division of HIV/AIDS Prevention's Strategy of Adopting HIV 
Treatment as Prevention; (3) Update on Division of Tuberculosis 
Elimination's Concept of Operations for Latent Tuberculosis Infection 
Surveillance; and (4) Update from ACET workgroups. Agenda items are 
subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-14755 Filed 7-10-18; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.